Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion.
Amy JamiesonMarcel GrubeSamuel LeungDerek ChiuAmy LumJanice S KwonAline TalhoukC Blake GilksStefan KommossJessica Nell McAlpinePublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
The recurrence rate in patients with stage IA p53abn endometrial cancer without myoinvasion was 16%, highest in the setting of residual endometrial disease (19%), and exceeding the threshold where adjuvant therapy is often considered. The high frequency of distant recurrences observed may support chemotherapy as part of the treatment regimen.